Compare $GTHP vs $ICU | Chartloom

Compare

$GTHP vs $ICU

Guided Therapeutics Inc · SeaStar Medical Holding Corp

GTHP

Guided Therapeutics Inc

ICU

SeaStar Medical Holding Corp

Compare $GTHP vs $ICU

Comparing Guided Therapeutics Inc and SeaStar Medical Holding Corp

GTHPGuided Therapeutics Inc

ICUSeaStar Medical Holding Corp

GTHPGuided Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-63.0%

52W performance

-20.0%

FCF yield

-7.8%

ICUSeaStar Medical Holding Corp

Market cap

$14M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

123.6%

YTD performance

37.2%

52W performance

-45.2%

FCF yield

-94.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTHP

ICU

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

ICU

SeaStar Medical Holding Corp

Market Cap

GTHP$19M

ICU$14M

Enterprise Value

GTHP$21M

ICU$8M

Price

GTHP$0.20

ICU$3.61

P/E Ratio

GTHPN/A

ICUN/A

P/S Ratio

GTHP29.70x

ICU8.43x

EV/Sales

GTHP32.92x

ICU4.45x

EV/EBITDA

GTHP0.00x

ICU0.00x

P/B Ratio

GTHP33.42x

ICU4.81x

P/FCF Ratio

GTHPN/A

ICUN/A

EV/FCF

GTHP-14.21x

ICU-0.56x

PEG Ratio

GTHPN/A

ICUN/A

Forward P/E (NTM)

GTHPN/A

ICUN/A

Forward P/S (NTM)

GTHPN/A

ICUN/A

Revenue (TTM)

GTHP$650K

ICU$2M

Revenue Growth (YoY)

GTHP450.8%

ICU123.6%

Forward Rev Growth

GTHP0.0%

ICU49.9%

Gross Margin (TTM)

GTHP75.8%

ICU92.6%

Operating Margin (TTM)

GTHP0.0%

ICU0.0%

EBITDA Margin (TTM)

GTHP-336.2%

ICU-816.6%

Net Margin (TTM)

GTHP-560.6%

ICU-795.5%

FCF Margin (TTM)

GTHP-231.7%

ICU-799.4%

Net Income (TTM)

GTHP$-4M

ICU$-14M

FCF (TTM)

GTHP$-2M

ICU$-14M

EPS (TTM)

GTHP-$0.04

ICU-$3.34

ROE (TTM)

GTHP-47148.0%

ICU-16275.0%

ROA (TTM)

GTHP-24393.0%

ICU-10990.0%

ROIC (TTM)

GTHP-37126.0%

ICU-15808.0%

Cash

GTHP$12K

ICU$7M

Debt

GTHP$2M

ICU$134K

Net Cash/Debt

GTHP$-2M

ICU$7M

Current Ratio (TTM)

GTHP0.09x

ICU1.89x

Quick Ratio (TTM)

GTHP0.00x

ICU1.65x

Debt/Equity (TTM)

GTHP0.60x

ICU0.03x

Debt/Assets (TTM)

GTHP0.0%

ICU0.0%

Interest Coverage (TTM)

GTHPN/A

ICUN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

ICU0.00x

Beta

GTHP0.69

ICU-1.12

52W Performance

GTHP-20.0%

ICU-45.2%

YTD Performance

GTHP-63.0%

ICU37.2%

% from 52W High

GTHP-63.0%

ICU-50.9%

% from 52W Low

GTHP66.7%

ICU74.4%

Asset Turnover (TTM)

GTHP0.73x

ICU0.14x

FCF Yield (TTM)

GTHP-7.8%

ICU-94.8%

Earnings Yield (TTM)

GTHP-18.9%

ICU-94.4%

Dividend Yield (TTM)

GTHPN/A

ICUN/A

Rule of 40

GTHP219.2

ICU-675.7

EV/GP/RG

GTHPN/A

ICU0.10

Ticker research

View GTHP research View ICU research

Metric	GTHP Guided Therapeutics Inc	ICU SeaStar Medical Holding Corp
Market & Valuation
Market Cap	$19M	$14M
Enterprise Value	$21M	$8M
Price	$0.20	$3.61
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	8.43x
EV/Sales	32.92x	4.45x
EV/EBITDA	0.00x	0.00x
P/B Ratio	33.42x	4.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-0.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$650K	$2M
Revenue Growth (YoY)	450.8%	123.6%
Forward Rev Growth	0.0%	49.9%
Profitability
Gross Margin (TTM)	75.8%	92.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-816.6%
Net Margin (TTM)	-560.6%	-795.5%
FCF Margin (TTM)	-231.7%	-799.4%
Net Income (TTM)	$-4M	$-14M
FCF (TTM)	$-2M	$-14M
EPS (TTM)	-$0.04	-$3.34
ROE (TTM)	-47148.0%	-16275.0%
ROA (TTM)	-24393.0%	-10990.0%
ROIC (TTM)	-37126.0%	-15808.0%
Financial Health
Cash	$12K	$7M
Debt	$2M	$134K
Net Cash/Debt	$-2M	$7M
Current Ratio (TTM)	0.09x	1.89x
Quick Ratio (TTM)	0.00x	1.65x
Debt/Equity (TTM)	0.60x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	-1.12
52W Performance	-20.0%	-45.2%
YTD Performance	-63.0%	37.2%
% from 52W High	-63.0%	-50.9%
% from 52W Low	66.7%	74.4%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.14x
FCF Yield (TTM)	-7.8%	-94.8%
Earnings Yield (TTM)	-18.9%	-94.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-675.7
EV/GP/RG	N/A	0.10
Ticker research	View GTHP research	View ICU research

Valuation

P/S Ratio

ICU

8.43x

GTHP

29.70x

EV/FCF

GTHP

-14.21x

ICU

-0.56x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

ICU

123.6%

Forward Revenue Growth

ICU

49.9%

GTHP

0.0%

Profitability & performance

Gross Margin

ICU

92.6%

GTHP

75.8%

ROE

ICU

-16275.0%

GTHP

-47148.0%

FCF Yield %

GTHP

-7.8%

ICU

-94.8%

52-Week Performance

GTHP

-20.0%

ICU

-45.2%

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

ICU

SeaStar Medical Holding Corp

Market Cap

GTHP$19M

ICU$14M

Enterprise Value

GTHP$21M

ICU$8M

Price

GTHP$0.20

ICU$3.61

P/E Ratio

GTHPN/A

ICUN/A

P/S Ratio

GTHP29.70x

ICU8.43x

EV/Sales

GTHP32.92x

ICU4.45x

EV/EBITDA

GTHP0.00x

ICU0.00x

P/B Ratio

GTHP33.42x

ICU4.81x

P/FCF Ratio

GTHPN/A

ICUN/A

EV/FCF

GTHP-14.21x

ICU-0.56x

PEG Ratio

GTHPN/A

ICUN/A

Forward P/E (NTM)

GTHPN/A

ICUN/A

Forward P/S (NTM)

GTHPN/A

ICUN/A

Revenue (TTM)

GTHP$650K

ICU$2M

Revenue Growth (YoY)

GTHP450.8%

ICU123.6%

Forward Rev Growth

GTHP0.0%

ICU49.9%

Gross Margin (TTM)

GTHP75.8%

ICU92.6%

Operating Margin (TTM)

GTHP0.0%

ICU0.0%

EBITDA Margin (TTM)

GTHP-336.2%

ICU-816.6%

Net Margin (TTM)

GTHP-560.6%

ICU-795.5%

FCF Margin (TTM)

GTHP-231.7%

ICU-799.4%

Net Income (TTM)

GTHP$-4M

ICU$-14M

FCF (TTM)

GTHP$-2M

ICU$-14M

EPS (TTM)

GTHP-$0.04

ICU-$3.34

ROE (TTM)

GTHP-47148.0%

ICU-16275.0%

ROA (TTM)

GTHP-24393.0%

ICU-10990.0%

ROIC (TTM)

GTHP-37126.0%

ICU-15808.0%

Cash

GTHP$12K

ICU$7M

Debt

GTHP$2M

ICU$134K

Net Cash/Debt

GTHP$-2M

ICU$7M

Current Ratio (TTM)

GTHP0.09x

ICU1.89x

Quick Ratio (TTM)

GTHP0.00x

ICU1.65x

Debt/Equity (TTM)

GTHP0.60x

ICU0.03x

Debt/Assets (TTM)

GTHP0.0%

ICU0.0%

Interest Coverage (TTM)

GTHPN/A

ICUN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

ICU0.00x

Beta

GTHP0.69

ICU-1.12

52W Performance

GTHP-20.0%

ICU-45.2%

YTD Performance

GTHP-63.0%

ICU37.2%

% from 52W High

GTHP-63.0%

ICU-50.9%

% from 52W Low

GTHP66.7%

ICU74.4%

Asset Turnover (TTM)

GTHP0.73x

ICU0.14x

FCF Yield (TTM)

GTHP-7.8%

ICU-94.8%

Earnings Yield (TTM)

GTHP-18.9%

ICU-94.4%

Dividend Yield (TTM)

GTHPN/A

ICUN/A

Rule of 40

GTHP219.2

ICU-675.7

EV/GP/RG

GTHPN/A

ICU0.10

Ticker research

View GTHP research View ICU research

Metric	GTHP Guided Therapeutics Inc	ICU SeaStar Medical Holding Corp
Market & Valuation
Market Cap	$19M	$14M
Enterprise Value	$21M	$8M
Price	$0.20	$3.61
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	8.43x
EV/Sales	32.92x	4.45x
EV/EBITDA	0.00x	0.00x
P/B Ratio	33.42x	4.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-0.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$650K	$2M
Revenue Growth (YoY)	450.8%	123.6%
Forward Rev Growth	0.0%	49.9%
Profitability
Gross Margin (TTM)	75.8%	92.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-816.6%
Net Margin (TTM)	-560.6%	-795.5%
FCF Margin (TTM)	-231.7%	-799.4%
Net Income (TTM)	$-4M	$-14M
FCF (TTM)	$-2M	$-14M
EPS (TTM)	-$0.04	-$3.34
ROE (TTM)	-47148.0%	-16275.0%
ROA (TTM)	-24393.0%	-10990.0%
ROIC (TTM)	-37126.0%	-15808.0%
Financial Health
Cash	$12K	$7M
Debt	$2M	$134K
Net Cash/Debt	$-2M	$7M
Current Ratio (TTM)	0.09x	1.89x
Quick Ratio (TTM)	0.00x	1.65x
Debt/Equity (TTM)	0.60x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	-1.12
52W Performance	-20.0%	-45.2%
YTD Performance	-63.0%	37.2%
% from 52W High	-63.0%	-50.9%
% from 52W Low	66.7%	74.4%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.14x
FCF Yield (TTM)	-7.8%	-94.8%
Earnings Yield (TTM)	-18.9%	-94.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-675.7
EV/GP/RG	N/A	0.10
Ticker research	View GTHP research	View ICU research